125 related articles for article (PubMed ID: 8123032)
1. Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity.
Casteels P; Tempst P
Biochem Biophys Res Commun; 1994 Feb; 199(1):339-45. PubMed ID: 8123032
[TBL] [Abstract][Full Text] [Related]
2. Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation.
Gobbo M; Benincasa M; Bertoloni G; Biondi B; Dosselli R; Papini E; Reddi E; Rocchi R; Tavano R; Gennaro R
J Med Chem; 2009 Aug; 52(16):5197-206. PubMed ID: 20560644
[TBL] [Abstract][Full Text] [Related]
3. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
Avrahami D; Shai Y
Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides: synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues.
Gobbo M; Biondi L; Filira F; Gennaro R; Benincasa M; Scolaro B; Rocchi R
J Med Chem; 2002 Sep; 45(20):4494-504. PubMed ID: 12238928
[TBL] [Abstract][Full Text] [Related]
5. Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action.
Li WF; Ma GX; Zhou XX
Peptides; 2006 Sep; 27(9):2350-9. PubMed ID: 16675061
[TBL] [Abstract][Full Text] [Related]
6. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.
Knappe D; Piantavigna S; Hansen A; Mechler A; Binas A; Nolte O; Martin LL; Hoffmann R
J Med Chem; 2010 Jul; 53(14):5240-7. PubMed ID: 20565063
[TBL] [Abstract][Full Text] [Related]
7. Nisin-controlled extracellular production of apidaecin in Lactococcus lactis.
Zhou XX; Wang YB; Pan YJ; Li WF
Appl Microbiol Biotechnol; 2008 Apr; 78(6):947-53. PubMed ID: 18286279
[TBL] [Abstract][Full Text] [Related]
8. Esculentin-1b(1-18)--a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli.
Marcellini L; Borro M; Gentile G; Rinaldi AC; Stella L; Aimola P; Barra D; Mangoni ML
FEBS J; 2009 Oct; 276(19):5647-64. PubMed ID: 19725877
[TBL] [Abstract][Full Text] [Related]
9. Biodiversity of apidaecin-type peptide antibiotics. Prospects of manipulating the antibacterial spectrum and combating acquired resistance.
Casteels P; Romagnolo J; Castle M; Casteels-Josson K; Erdjument-Bromage H; Tempst P
J Biol Chem; 1994 Oct; 269(42):26107-15. PubMed ID: 7929322
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
Wu M; Maier E; Benz R; Hancock RE
Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835
[TBL] [Abstract][Full Text] [Related]
11. Functional mapping of apidaecin through secondary structure correlation.
Dutta RC; Nagpal S; Salunke DM
Int J Biochem Cell Biol; 2008; 40(5):1005-15. PubMed ID: 18083056
[TBL] [Abstract][Full Text] [Related]
12. Functional and structural characterization of apidaecin and its N-terminal and C-terminal fragments.
Zhou XX; Li WF; Pan YJ
J Pept Sci; 2008 Jun; 14(6):697-707. PubMed ID: 18076126
[TBL] [Abstract][Full Text] [Related]
13. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli.
Lee JH; Minn I; Park CB; Kim SC
Protein Expr Purif; 1998 Feb; 12(1):53-60. PubMed ID: 9473457
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.
Fernandez-Lopez S; Kim HS; Choi EC; Delgado M; Granja JR; Khasanov A; Kraehenbuehl K; Long G; Weinberger DA; Wilcoxen KM; Ghadiri MR
Nature; 2001 Jul; 412(6845):452-5. PubMed ID: 11473322
[TBL] [Abstract][Full Text] [Related]
16. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.
Zhang L; Benz R; Hancock RE
Biochemistry; 1999 Jun; 38(25):8102-11. PubMed ID: 10387056
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and photoinduced antibacterial activity of porphyrin-type photosensitizers conjugated to the antimicrobial peptide apidaecin 1b.
Dosselli R; Tampieri C; Ruiz-González R; De Munari S; Ragàs X; Sánchez-García D; Agut M; Nonell S; Reddi E; Gobbo M
J Med Chem; 2013 Feb; 56(3):1052-63. PubMed ID: 23231466
[TBL] [Abstract][Full Text] [Related]
18. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue.
Dempsey CE; Ueno S; Avison MB
Biochemistry; 2003 Jan; 42(2):402-9. PubMed ID: 12525167
[TBL] [Abstract][Full Text] [Related]
19. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
20. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
